Dr Raymond Stein was an invited guest speaker to the Canadian Ophthalmological Society annual meeting in Toronto on June 2, 2018 to discuss a new Corneal Laser for Age-related Macular Degeneration (AMD). This low energy laser has recently been approved by Health Canada. The Bochner Eye Institute becomes the first approved centre in North America to use this innovative technology. The laser alters the cornea to redirect light to the back of the eye to a location outside of the blind spot. Clinical outcomes have been positive in terms of improved vision and enhancement of quality of life.
